LYRA - Lyra Therapeutics Net Sales Margin

Public company logo of Lyra Therapeutics Inc. (LYRA)

The development of non-invasive treatments for ENT diseases in the US is opening new markets. The net profit margin exhibits volatility, where the 0.00 level records fresh values. Lyra Therapeutics, Inc. (LYRA) plans the global rollout of the XTreo system to combat sinusitis; however, failures in late-stage trials have created an acute liquidity crisis, jeopardizing future developments.

LYRA: lyratherapeutics.com Net Profit Rate 07/04/2022 - 03/28/2026

Lyra Therapeutics, Inc (LYRA) - metric breakdowns and financial figures

- market value and analyst target forecast:
Comprehensive company analysis:Lyra Therapeutics, Inc.
Flagship merchandise of Lyra Therapeutics Inc.

Lyra Therapeutics, Inc. (LYRA) leverages its niche leadership in ENT therapy to command premium pricing for its proprietary developments. This strategy is reflected in the calculation of net profit as a share of total revenue. This metric measures the business's ability to convert sales into actual capital, filtering out short-term market volatility. A critical decline in this ratio signals rising costs or intensifying competition. The business's resilience is clearly illustrated by the adjusted net profit margin.

Who Lyra Therapeutics, Inc. competes with

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Cumberland Corp - Net Sales Margin|QNTM - Net Sales Margin|FibroGen, Inc. (FGEN) - Net Margin|TELO: Company Net Profitability|RANI (Rani Therapeutics Inc) - Net Sales Margin|Net Margin synergychc.com SNYR|Net Margin Rallybio Corp. (RLYB)|LEXX - Net Margin|Net Sales Margin PULM (pulmatrix.com)|Company Net Profitability PTHL (Pheton)|APM - Net Margin|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma